Simplify Logo

Full-Time

National Strategic Accounts Senior Manager

West

Updated on 9/5/2024

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell receptors for diagnostics

Hardware
Biotechnology
Healthcare

Compensation Overview

$164k - $246kAnnually

+ Equity Grant + Incentive Compensation + Transportation Reimbursement

Senior, Expert

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Marketing
Business Strategy
Requirements
  • BA/BS in Life Sciences or related field + 12 years of related experience (oncology/hematology, biotech, life science, or diagnostic sales and/or Oncology lab service background a plus) or Master's degree in Life Sciences or related field + 10 years of related experience.
  • Minimum of 5 years' experience in account management and oncology/hematology marketplace.
  • Demonstrated ability to pull together insights from various sources and develop strategic business plans that result in a business decision, action, and sales results.
  • Demonstrated communication and teamwork skills; ability to gain alignment and act within a matrix team environment; ability to work in a collaborative and influencing fashion that drives business results.
  • Exceptional business acumen and understanding of community-based network landscape.
  • Clinical knowledge and proficiency in selling in the clinical oncology/hematology marketplace.
  • Ability to establish relationships with high-level Executive and Management personnel.
Responsibilities
  • Demonstrate knowledge of, access to, and the ability to influence all key stakeholders in assigned community-based network accounts to drive sales. (Oncologists/Hematologist, Hematology Pathologist, Practice Leaders, Advanced Practice Providers, Lab personnel, and Supportive Personnel)
  • Partner cross-functionally with external and internal stakeholders to execute pull-through business plans and serve as the customer-facing leader for assigned community-based network accounts.
  • Develop, execute, and lead business strategy to drive utilization and adoption for assigned strategic community-based network accounts within the given region.
  • Monitor product utilization, penetration, and other key performance metrics within assigned accounts.
  • Effectively build a short/medium/long term sales pipeline and manage the necessary levels of sales leads, prospects, and opportunities.
  • Deliver compelling sales presentations: close initial business, follow-up, and identify repeat business while building a network of referrals.
  • Participate in/facilitate account agreements, educational programs, training, and customer support efforts working with Adaptive's internal partners. (DHS, Account Managers, Clinical Services, Market Access, Marketing, Medical Affairs, etc.)
  • Build a comprehensive knowledge of customers and prospects, including the overall market, customer needs, personnel and responsibilities, budgeting, knowing their funding processes, and the competition.
  • Develop and lead initiatives to drive Adaptive's business imperatives and sales with State Societies, Regional Associations, and other regional strategic partners. (E.g., FLASCO, TxSCO, TOPS, etc.)
  • Attend identified relevant national/regional/local education meetings and conferences, maximizing opportunities at these events to deepen and expand Adaptive's business and credibility.
  • Self-directed and results-oriented; act as a change agent and make decisions in a dynamic environment with internal and external challenges.
  • Excellent communication skills (oral, written, and presentation); ability to present ideas and evidence-based scientific and economic data to customers in a way that produces understanding and impact.
  • Comply with all Federal and State laws, regulations, and policies that govern the conduct of Adaptive's activities.
  • Provide test access to clinicians through creating and implementing avenues for easy if not automatic ordering through protocols, pathways, standing orders, order forms, EMR integration while also advancing value added projects that benefit the practice and patients.
  • Identify and develop KOL advocates to influence perspectives on testing in the account, region, network and nation.
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue by partnering with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare solutions for various diseases.

Company Stage

IPO

Total Funding

$575.5M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-8%

2 year growth

-10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Adaptive Biotechnologies' partnerships with pharmaceutical companies and healthcare providers offer significant growth opportunities and revenue streams.
  • Winning the Workplace of the Year Award highlights their strong company culture and employee satisfaction, making it an attractive place to work.
  • Their collaboration with BeiGene on minimal residual disease measurement could lead to groundbreaking advancements in cancer treatment.

What critics are saying

  • The departure of key board members like Kevin Conroy and Leslie Trigg could lead to strategic instability.
  • The highly competitive biotechnology sector requires continuous innovation to maintain market position.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages the genetic information of immune cell receptors to develop advanced diagnostic tools and treatments, setting it apart from traditional biotech firms.
  • Their ImmuneRACE study, focusing on COVID-19 immune response, showcases their commitment to addressing current global health challenges.
  • The integration of their clonoSEQ® assay with Epic systems enhances their diagnostic capabilities, providing a seamless experience for healthcare providers.